Dr. Mullett, Medical Director, Markey Cancer Center Affiliate Network, is a surgical oncologist who specializes in the treatment of lung cancer. Although he began his career at the University of Kentucky as a cardiothoracic surgeon treating heart issues, he soon shifted his professional focus to treating lung cancer, one of the state’s major health problems. Today, he is a co-leader and principal investigator of the Kentucky LEADS Collaborative to improve lung cancer survival. In addition to his work in lung cancer research, Dr. Mullett serves as the chair of UK’s cancer committee and the medical director of the Markey Cancer Center Research Network, a collaborative network that conducts high priority trials including therapeutic oncology trials and interventional and non-interventional studies for community centers. Dr. Mullett currently serves as chair of the Commission on Cancer (CoC) of the American College of Surgeons (ACS)
Selected publications from PubMed
Lung Cancer Screening Prevalence and Changes in 2024.
Burus T, McAfee CR, Knight JR, Mullett TW, Hull PC
JAMA Intern Med. 2026 Jun 1;186(6):775-778 doi: 10.1001/jamainternmed.2026.0493.
The American Cancer Society National Lung Cancer Roundtable strategic plan: Strengthening connections between state-based initiatives.
Olson JMG, Knight JR, Copeland AM, Mei LS, Kinney AY, Tupper HI, Ohlander KA, Rosenthal LS, Burson HC, Hofmann KE, Bathje KH, Mullett TW, Kazerooni EA, Smith RA
Cancer. 2025 Dec 1;131(23):e70143 doi: 10.1002/cncr.70143.
The American Cancer Society National Lung Cancer Roundtable strategic plan: Addressing planning for lung cancer interventions at the state and local level through the creation of the National Lung Cancer Roundtable Planning Tool.
Olson JMG, Knight JR, Copeland AM, Ohlander KA, Bathje KH, Burson HC, Domingo CA, Durden KA, Dickson-Gavney E, Hofmann KE, Mullett TW, Rosenthal LS, Kazerooni EA, Wood DE, Smith RA
Cancer. 2025 Aug 15;131(16):e35954 doi: 10.1002/cncr.35954.
Smoking Status of the US Cancer Population and a New Perspective From the National Cancer Database.
Caturegli G, Zhu X, Palis B, Mullett TW, Resio BJ, Boffa DJ
JAMA Oncol. 2025 May 1;11(5):564-566 doi: 10.1001/jamaoncol.2025.0247.
Getting ready for prime time: Recommended adaptations of an Empathic Communication Skills training intervention to reduce lung cancer stigma for a national multi-center trial.
Banerjee SC, Malling CD, Shen MJ, Williamson TJ, Bylund CL, Studts JL, Mullett T, Carter-Bawa L, Hamann HA, Parker PA, Steliga M, Feldman J, Pantelas J, Borondy-Kitts A, Rigney M, King JC, Fathi JT, Rosenthal LS, Smith RA, Ostroff JS
Transl Behav Med. 2023 Sep 28;13(10):804-808 doi: 10.1093/tbm/ibad048.
Help your network discover Dr. Timothy Mullett's clinical expertise.
.jpg)